# Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia

Study · id `cardio:ct-nct07511257` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07511257](<https://clinicaltrials.gov/study/NCT07511257>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07511257

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 326 participants.

## Technical summary

Registry record NCT07511257. Randomized; no masking; primary purpose treatment. Start 2026-02-11 (actual); primary completion 2029-06 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 326 participants (planned count; ClinicalTrials.gov record NCT07511257, source copy `cardio:ctgov-nct07511257-2026-04-09`, retrieved 2026-11-18)
- Started: 2026-02-11 (actual) (ClinicalTrials.gov record NCT07511257, source copy `cardio:ctgov-nct07511257-2026-04-09`, retrieved 2026-11-18)
- Primary completion: 2029-06 (anticipated) (ClinicalTrials.gov record NCT07511257, source copy `cardio:ctgov-nct07511257-2026-04-09`, retrieved 2026-11-18)
- Completion: 2029-06 (anticipated) (ClinicalTrials.gov record NCT07511257, source copy `cardio:ctgov-nct07511257-2026-04-09`, retrieved 2026-11-18)
- Countries: Mexico (ClinicalTrials.gov record NCT07511257, source copy `cardio:ctgov-nct07511257-2026-04-09`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07511257-2026-04-09`, retrieved 2026-11-18)

## The registry's words

- Brief title: Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia
- Acronym: OVER-TIME II
- Condition: Coronary Artery Ectasia
- Condition: Acute Coronary Syndromes (ACS)
- Condition: STEMI - ST Elevation Myocardial Infarction
- Condition: NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)
- Intervention (Drug): Aspirin 100 mg
- Intervention (Drug): Clopidogrel 75 mg
- Intervention (Drug): Rivaroxaban 15 mg
- Lead sponsor: Instituto Nacional de Cardiologia Ignacio Chavez
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Instituto Nacional de Cardiologia Ignacio Chavez (`cardio:org-instituto-nacional-de-cardiologia-ignacio-chavez`)

## Provenance

Content hash: 8476f63ca89d63dbf8b4d056828d81aa6c54620c10d4d6bca34e8e9abfc46291
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
